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1. Introduction 
Mitochondria isolated from ischaemic tissues or 
‘aged’ in vitro exhibit a diminished capacity for oxida- 
tive phosphorylation [l-4] . Among the factors impli- 
cated has been the liberation of free fatty acids (FFAs) 
which have been demonstrated to be potent uncoil- 
plers of oxidative phosphorylation [5] . 
A similar deterioration of function was observed 
during a study of the effects of anoxia upon isolated 
mitochondria. Determination of liberated FFAs in 
such experiments revealed an increase not only in 
medium chain FFAs, but also in polyunsaturated long 
chain FFAs which are known precursors of the 
prostaglandins. Since the effects of anoxia have been 
implicated in cell injury, the elaboration of such 
prostaglandin precursors may have a role in the cell’s 
response to anoxic injury. 
2. Materials and methods 
Mitochondria were isolated from the livers of male 
Sprague-Dawley rats (50-140 g) by the procedure 
of Weinbach [6]. The isolation medium consisted of 
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0.25 M sucrose; 10 mM Tris-HCl (pH 7.4); 0.5 mM 
K-EDTA; 0.5 mM K-EGTA. 
A polarographic technique was employed for the 
production of in vitro anoxia and for the determina- 
tion of oxidative phosphorylation. Mitochondria were 
suspended in a medium with a final concentration of 
17.9 mM sucrose; 19.3 mM Tris-HCl (pH 7.4); 1 .O 
mM K-EDTA; 1 .O mM K-EGTA; 111.4 mM KCL; 4.6 
mM MgClz ; 4.6 mM K-phosphates (pH 7.4); 20 mM 
sodium succinate. Mitochondria were present at a 
level of 1.4-l .7 mg protein/ml. 
Anoxia was producted by the exhaustion of O2 in 
the polarograph vessel through repeated addition of 
ADP. When the polarograph recorder trace indicated 
zero O2 content in the medium, the mitochondria 
were maintained in that environment for varying dura- 
tions. A 3-hour control experiment was also carried 
out in order to determine the effect of unlimited 
oxygenation on the experimental system. 
Protein was determined by the Biuret method [7]. 
Mitochondrial lipids were extracted by the method 
of Garbus et al. [8]. Heptadecanoic acid (C17:O; 
Sigma) was added to the crude extract as an internal 
standard to correct for losses during work-up. The 
solvent phase of the crude extract was collected, 
evaporated under Nz, and reconstituted in 1 .O ml of 
chloroform. FFAs were recovered by a modification 
of the procedure described by Dittmer and Wells [9]. 
FFAs were esterified using BC13 -MeOH (10% w/v; 
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Applied Sciences Laboratories). The FFA methyl 
esters were reconstituted in 50-100 ~1 of hexane 
(Lipopure; Applied Sciences Laboratories), and used 
immediately for CLC. 
GLC was carried out using a Packard Series 7834 
Gas Chromatograph. Packing consisted of 15% EGSS- 
X with Gas Chrom P (1 OO/ 120 mesh) as support 
(Applied Sciences Laboratories). Carrier gas was Nz 
at a flow rate of 60 ml/min. Flame ionization detec- 
tor response was maximized by adjusting Hz flow. 
Qualitative and quantitative mixtures of FFA methyl 
esters were obtained from Sigma Chemical Co., 
Applied Sciences Laboratories, and Supelco, Inc. The 
peaks were identified by retention times relative to 
C 18:0 and by positions of known standards. Quantita- 
tion of peak areas was carried out by the triangula- 
tion method, the area of C 17:O serving as the quanti- 
tative reference peak. 
3. Results and discussion 
Oxidative function of mitochondria deprived of 
O2 for varying durations versus mitochondria main- 
tained in an aerobic environment for three hours is 
summarized in table 1. Mitochondria maintained in an 
anoxic state exhibited an initial decline in State III 
rate with an increase in State IV rate occurring after 
two hours of anoxia. This resulted in a continuous 
deterioration of the RCI. although ADP/O ratios 
remained relatively intact. After three hours of anoxia 
there was total loss of the RCI and the ADP/O ratio. 
In contrast, although mitochondria maintained in an 
aerobic environment for three hours exhibited an 
initial decline in respiration in State III, the slight 
alternation in State IV rates ensured a degree of 
respiratory control and oxidative phosphorylation. 
As it was assumed that the functional deterioration 
of anoxic mitochondria was a consequence of the 
elaboration of an endogenous uncoupler, presumably 
FFAs, extracts of the anoxic mitochondria were ana- 
lyzed for FFAs by gas-liquid chromatography. 
Table 2 shows the concentrations of FFAs recovered 
after one, two and three hours of mitochondrial anoxia, 
and the FFAs identified in the three-hour aerated 
control. The concentrations of all FFAs rise as the 
anoxic interval is prolonged. This rise seems most 
apparent in the saturated FFAs, C16:O and C18:O. 
The rise in the unsaturated FFAs is progressive but of 
lesser magnitude than the rise in the saturated FFAs. 
However, while the concentrations of C 16:O and 
C 18:O after three hr of anoxia are approximately 3--4 
times their zero time levels, the concentration of 
C 20:4 is approximately 24 times its zero time value. 
Furthermore, after three hr of anoxia the ratio of 
total saturated FFAs to total unsaturated FFAs 
approximates 1: 1. It is readily apparent that the 
concentration of FFAs recovered in the three-hour 
control is much below the concentration of FFAs in 
the zero time control. 
In the present study we have demonstrated that 
mitochondria rendered anoxic in a polarographic 
medium elaborate increasing amounts of FFAs as is 
found with mitochondria ‘aged’ in vitro or in 
Table 1 
Oxidative function of anoxic mitochondria compared to aerobic mitochondria 
Time 
(hr) 
Anoxic 
State III + State Iv” 
nAOz /min/mg 
RCl* ADP/O Time 
(hr) 
Aerobic 
State III + State IV” RCI* 
nA0, /min/mg 
ADP/O 
0 87.29 15.38 5.76 2.41 0 87.11 13.21 6.59 2.21 
1 32.99 11.94 2.76 2.33 1 21.78 9.32 2.34 2.66 
2 42.17 30.08 1.40 2.19 2 21.78 13.93 1.56 2.51 
3 39.63 39.63 1.00 0.00 3 22.49 14.28 I.57 1.57 
After the anoxic period, portions of the mitochondrial suspensions were re-oxygenated, and their function determined polaro- 
graphically. The control consisted of a suspension of mitochondria which was continuously exposed to the atmosphere. 
+ State III -rate of oxidation in the presence of ADP and substrate 
” State IV -rate of oxidation in the presence of substrate after the exhaustion of added ADP 
* RCI -respiratory control index; the ratio of State III to State IV rates 
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Table 2 
Concentration of free fatty acids under various conditions* 
Free 
fatty acid 
Control 
(0 time) 
One hr 
Anoxia 
Two hr 
Anoxia 
Three hr 
Anoxia 
Three hr 
Control+ 
C16:O 1.68 3.25 5.09 5.19 0.76 
C18:O 1.15 4.09 6.91 3.74 0.32 
C18:l 0.85 1.28 1.68 3.23 0.29 
C18:2 0.44 1.23 2.10 2.22 0.05 
c20:2 0.22 0.08 0.15 0.25 0.06 
C20:4 0.08 0.55 1.39 1.87 0.02 
c20:5 0.00 0.16 0.35 0.25 0.00 
C22:6 0.00 0.11 0.21 0.19 0.00 
Total 4.42 10.75 17.88 16.94 1.50 
FFAs were extracted and quantified by GLC as described in Materials and methods. 
* Expressed as nmol of free acid per milligram of mitochondrial protein. 
+ FFAs recovered after 3 hr under aerated conditions. 
mitochondria isolated from ischaemic tissue. Concom- 
itant with this rise in FFA concentration, deterioration 
of oxidative function is observed. However, if mito- 
chondria are maintained in an oxygenated medium 
for similar periods of time, there is no accumulation 
of FFAs, and oxidative function is relatively intact. 
The mechanisms by which anoxic mitochondria or 
mitochondria isolated from ischaemic tissue or aged 
in vitro accumulate FFAs can be attributed to the 
activity of lipases [2--41 and the inhibition of oxida- 
tion, either directly or by inhibition of the fatty acid 
activating system. As mitochondrial function deterio- 
rates as a consequence of anoxia, sequestered Ca2+ 
could be released activating phospholipases and the 
liberated FFAs would accumulate due to the 
inhibition of P-oxidation. 
In the present study, the initial rise in FFAs was 
largely due to saturated FFAs even though these 
saturated fatty acids acount for only 33% of the total 
mitochondrial fatty acids [lo] . Of more interest is 
the proportionately greater increase in the polyunsatu- 
rated FFAs C 20:4, C 20:s and C 22:6. Also, the 
fatty acids, C 20:2, C 20:5 and C 22:6 which were 
found in mitochondria rendered anoxic for l-3 hr 
were nor previously reported in aged mitochondria 
[3], nor in mitochondria isolated from ischaemic liver 
[4] . These longer chain polyunsaturated fatty acids 
are known precursors of prostaglandins of the E and 
F series [ 111. As the liver has been shown to possess 
the enzymatic complement needed for prostaglandin 
synthesis [ 121, the accumulation of these known 
prostaglandin precursors may represent the penulti- 
mate step for synthesis of prostaglandins. 
The synthesis and release of prostaglandins may 
represent a mechanism by which the cell deals with 
the deleterious effect of anoxia. Support for this 
hypothesis comes from studies demonstrating increased 
levels of prostaglandin released from tissues rendered 
ischaemic [13-181. Furthermore, unpublished obser- 
vations in this laboratory have shown an increase with 
time in endogenous FFAs in various organs rendered 
anoxic that parallel the organs’ susceptibility to 
ischaemic damage. 
That mitochondria may be the regulators of the 
levels of prostagladins during ischaemic episodes in 
intact cells is an intriguing concept. The mechanisms 
through which mitochondria may provide precursors 
for prostaglandins in ischaemia have been discussed 
above. When the ischaemic episode ceases and an 
increased level of O2 is available to the mitochondria 
P-oxidation of accumulated FFAs would be stimulated, 
Ca2+ resequestered, and endogenous prostaglandins 
metabolized by mitochondria as described by Hamberg 
[ 191. The shift in the NAD’INADH ratio would also 
enhance the activity of the cytoplasmic prostaglandin 
degradation system [20,21]. 
This proposed mitochondrial control of prosta- 
glandin levels would have a teleological purpose. The 
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synthesis of prostaglandins from elaborated FFAs not 
only would protect the cell from the deleterious 
effects of uncoupling, but also would provide a poteni 
messenger to signal the local environment and the 
systemic circulation of the ischaemic cell’s plight. 
With the restoration of the availability of 02, mito- 
chondria would function to lower the levels of intra- 
cellular prostaglandin, and thus effectively counter 
its role as a messenger. 
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